<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — Oktober 2022]]></title><description><![CDATA[<p dir="auto">Gratis varme <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=d361a5e1ce4" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/399165/genmab-oktober-2022</link><generator>RSS for Node</generator><lastBuildDate>Mon, 08 Jun 2026 18:22:37 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/399165.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 01 Oct 2022 05:23:37 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 14:38:58 GMT]]></title><description><![CDATA[<p dir="auto">'While AbbVie does face several near-term pressures, we believe the firm is making strides with its pipeline, but probably needs to augment internal efforts with increased acquisitions. Within the pipeline, we are bullish on recently filed lymphoma drug epcoritamab.' <a href="https://www.morningstar.com/articles/1121828/abbvie-posts-solid-q3-earnings-but-uncertain-outlook-for-humira-likely-weighing-on-stock" rel="nofollow ugc">https://www.morningstar.com/articles/1121828/abbvie-posts-solid-q3-earnings-but-uncertain-outlook-for-humira-likely-weighing-on-stock</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658539</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658539</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Oct 2022 14:38:58 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 12:44:03 GMT]]></title><description><![CDATA[<p dir="auto">Y-mAbs Therapeutics with many former Genmab employees -49% atm on negative FDA decision on their neuroblastoma drug. (now trading at $4.50, were at $54 end2020...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658542</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658542</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Oct 2022 12:44:03 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 12:07:47 GMT]]></title><description><![CDATA[<p dir="auto">Hov det var den forkerte tråd</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658537</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658537</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Mon, 31 Oct 2022 12:07:47 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 11:33:10 GMT]]></title><description><![CDATA[<p dir="auto">Ikke dårligt for RAPT Therapeutics da RPT193 gerne skulle ende op med en bedre safety profil</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658540</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658540</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Mon, 31 Oct 2022 11:33:10 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 11:32:38 GMT]]></title><description><![CDATA[<p dir="auto"><a href="https://endpts.com/ema-limits-use-of-jak-inhibitors-for-at-risk-groups-in-wake-of-safety-concerns/" rel="nofollow ugc">https://endpts.com/ema-limits-use-of-jak-inhibitors-for-at-risk-groups-in-wake-of-safety-concerns/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658535</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658535</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Mon, 31 Oct 2022 11:32:38 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Mon, 31 Oct 2022 04:55:23 GMT]]></title><description><![CDATA[<p dir="auto">Se ugens mange regnskaber: <a href="https://www.proinvestor.com/finanskalender" rel="nofollow ugc">https://www.proinvestor.com/finanskalender</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658534</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658534</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Oct 2022 04:55:23 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Sun, 30 Oct 2022 06:50:06 GMT]]></title><description><![CDATA[<p dir="auto">Highlight Abbvie Earnings Call "We're seeking accelerated approval based on the positive Phase 2 study results for epcoritamab in this indication where we saw very deep and durable responses in these highly refractory patients. We expect decisions in both U.S. and Europe in 2023."</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658536</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658536</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Sun, 30 Oct 2022 06:50:06 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Sat, 29 Oct 2022 07:12:23 GMT]]></title><description><![CDATA[<p dir="auto">I et bear-marked, hvor der raser recession på de økonomiske globale markeder, er det vigtig, man som investor har polstret sine porteføljer med aktier, som er både stresstestet og trykprøvet i deres evne til ikke at falde dybt ned, når der kommer negative nyheder. Og hvilke sektorer og aktier mener jeg, det er godt at være i? Det kan du høre om i denne video. <a href="https://www.proinvestor.com/boards/107378" rel="nofollow ugc">https://www.proinvestor.com/boards/107378</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658538</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658538</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Sat, 29 Oct 2022 07:12:23 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Sat, 29 Oct 2022 05:39:47 GMT]]></title><description><![CDATA[<p dir="auto">Godformiddag kl. er 11.27 her i Tyrkiet mon vi opholder os på de samme breddegrader kkjoel? vi fik det lokale sprøjt, men til gengæld lammenyrer, solgte desværre en del i 2890 så ingen årgangsvine her.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658541</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658541</guid><dc:creator><![CDATA[Doublo]]></dc:creator><pubDate>Sat, 29 Oct 2022 05:39:47 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 18:28:15 GMT]]></title><description><![CDATA[<p dir="auto">Gmab endte i 2920 DKkr.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658532</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658532</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 28 Oct 2022 18:28:15 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 18:22:58 GMT]]></title><description><![CDATA[<p dir="auto">Ikke noget nyt fra AbbVie.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658531</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658531</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 28 Oct 2022 18:22:58 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 18:22:28 GMT]]></title><description><![CDATA[<p dir="auto">Åbning mandag ?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658530</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658530</guid><dc:creator><![CDATA[Legolas23]]></dc:creator><pubDate>Fri, 28 Oct 2022 18:22:28 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 18:21:53 GMT]]></title><description><![CDATA[<p dir="auto">Ser man adds i us over hele handelsdagen laver den en Brontosaurus, der spiser palmeblade og kombineret med de største indeks luk i US forudser jeg en fin generel åbning. Jeg er forventningsfuld.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658529</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658529</guid><dc:creator><![CDATA[Legolas23]]></dc:creator><pubDate>Fri, 28 Oct 2022 18:21:53 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 16:29:34 GMT]]></title><description><![CDATA[<p dir="auto">AbbVie Inc. (ABBV) Q3 2022 Earnings Call Transcript<br />
<a href="https://seekingalpha.com/article/4550412-abbvie-inc-abbv-q3-2022-earnings-call-transcript" rel="nofollow ugc">https://seekingalpha.com/article/4550412-abbvie-inc-abbv-q3-2022-earnings-call-transcript</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658543</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658543</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Fri, 28 Oct 2022 16:29:34 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 14:24:33 GMT]]></title><description><![CDATA[<p dir="auto">Her blir det moden Chateauneuf du Pape (2012 Pégau, Cuvée Laurence) til pandestegt Shawarmakød med hele baduljen: humus, Ajvar, grovpita, salat m/hvidløgsdressing og feta, oliven, den hotte strøg-chili(!) og turşu-chilier (tyrkiske sursyltede, milde grønne chilipebre). God weekend og Bon appetit <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f609.png?v=d361a5e1ce4" class="not-responsive emoji emoji-android emoji--wink" style="height:23px;width:auto;vertical-align:middle" title=";-)" alt="😉" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658528</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658528</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 28 Oct 2022 14:24:33 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 14:07:47 GMT]]></title><description><![CDATA[<p dir="auto">NBI +2.58%</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658527</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658527</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 28 Oct 2022 14:07:47 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 14:03:20 GMT]]></title><description><![CDATA[<p dir="auto">Det jo trods alt en forskel i profit på 40% så det kan blive alvorligt hvis Genmab lander tæt på de 3.8</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658524</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658524</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 28 Oct 2022 14:03:20 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:59:53 GMT]]></title><description><![CDATA[<p dir="auto">Spændt på Q3 og opdateret guiding. Alt andet lige mp Genmab kunne indsnævre de 3.8-5.4 til et tal som er indenfor +/-200 mil kr</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658525</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658525</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:59:53 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:56:44 GMT]]></title><description><![CDATA[<p dir="auto">Fik købt en ekstra, kort klump i 2430, d. 26.09 (hvor kursen åbenlyst var kommet aaalt for langt ned) - mhp. nemme 20% INDEN nytår. Solgte - med lidt ekstra forsigtighed in mente - så meget af klumpen i går, at årets fortjeneste til lav skattesats nu er realiseret. Har typisk afholdt mig fra den slags dispositioner.. men den skal da bare have gas fremover, når GEN - sine 1-2 gange om året - falder 20-30% tilbage.. selv med 42% skattesats er det en overordentlig fin forretning!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658533</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658533</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:56:44 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:56:31 GMT]]></title><description><![CDATA[<p dir="auto">TA indikere dog stadig køb.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658519</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658519</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:56:31 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:52:33 GMT]]></title><description><![CDATA[<p dir="auto">Nu rykker NBI jo også 2.5% så set ud fra det lader det ikke til Epco filing har været trigger til dagens stigning for så skulle Genmab jo have rykket pænt over 2.5%. Men det kan selvfølgelig være det sker på Mandag når markedet har evalueret casen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658520</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658520</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:52:33 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:20:33 GMT]]></title><description><![CDATA[<p dir="auto">Kursen i US følger pænt med, nu 2904</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658521</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658521</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:20:33 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:01:18 GMT]]></title><description><![CDATA[<p dir="auto">Super;-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7658516</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658516</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:01:18 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2022 on Fri, 28 Oct 2022 13:00:57 GMT]]></title><description><![CDATA[<ol start="2906">
<li>Sådan.</li>
</ol>
]]></description><link>https://dev.proinvestor.com/forum/post/7658522</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7658522</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 28 Oct 2022 13:00:57 GMT</pubDate></item></channel></rss>